Connect with us about ICLUSIG® (ponatinib)

Complete the form below to receive more information

*Indicates a required field.

By selecting “Submit” below and providing your personal and/or medical data above, you certify that you are at least 18 years old, and that you are authorizing Takeda to use your data to provide you with information about products and disease-states from Takeda, its affiliates, service providers, and co-promotion partners. In addition to information about ICLUSIG, leukemia, and related health conditions or treatments, you understand this may include information about financial assistance programs, clinical trials and market research opportunities, and other support services or programs Takeda may in the future develop for patients. You also authorize Takeda to use your de-identified information to help Takeda improve and develop products, services, materials, and programs or for health economic outcomes and market research. 

Takeda respects your personal information. All personal and/or medical information you have provided will be kept confidential and will not be used or distributed to anyone for any purpose other than what is explained in our Privacy Notice. This consent will be in effect until such times as you opt out of the program.